582 related articles for article (PubMed ID: 18160186)
1. Immune responses to polysaccharides: lessons from humans and mice.
González-Fernández A; Faro J; Fernández C
Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
[TBL] [Abstract][Full Text] [Related]
2. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
Blanchard-Rohner G; Pollard AJ
Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
[TBL] [Abstract][Full Text] [Related]
3. Conjugated polysaccharide vaccines.
Ahmad H; Chapnick EK
Infect Dis Clin North Am; 1999 Mar; 13(1):113-33, vii. PubMed ID: 10198795
[TBL] [Abstract][Full Text] [Related]
4. Present status of polysaccharide vaccines in the prevention of meningococcal disease.
Gold R; Lepow ML
Adv Pediatr; 1976; 23():71-93. PubMed ID: 12651
[No Abstract] [Full Text] [Related]
5. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
6. [Bacterial polysaccharide vaccines: Meningococcus, Pneumococcus, Haemophilus influenzae].
Triau R
Rev Prat; 1984 Jun; 34(31):1683-90. PubMed ID: 6429835
[No Abstract] [Full Text] [Related]
7. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
[TBL] [Abstract][Full Text] [Related]
8. Disease transmission: routes, contributing factors and herd immunity.
O'Brien K
Int J Clin Pract Suppl; 2001 Feb; (118):5-7. PubMed ID: 11715363
[No Abstract] [Full Text] [Related]
9. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
[TBL] [Abstract][Full Text] [Related]
10. Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report.
Lepow ML; Gold R
N Engl J Med; 1983 May; 308(19):1158-60. PubMed ID: 6403865
[No Abstract] [Full Text] [Related]
11. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines.
Poolman J; Borrow R
Expert Rev Vaccines; 2011 Mar; 10(3):307-22. PubMed ID: 21434799
[TBL] [Abstract][Full Text] [Related]
12. [Polysaccharide vaccines against Haemophilus influenzae type B].
Wysokińska T; Janaszek W
Przegl Epidemiol; 1994; 48(1-2):39-44. PubMed ID: 8073141
[TBL] [Abstract][Full Text] [Related]
13. [Polysaccharide subunit vaccines].
Reinert P
Rev Prat; 1995 Jun; 45(12):1484-7. PubMed ID: 7660000
[TBL] [Abstract][Full Text] [Related]
14. Conjugate vaccines--a breakthrough in vaccine development.
Mäkelä PH
Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):249-53. PubMed ID: 12971544
[TBL] [Abstract][Full Text] [Related]
15. Use of animal testing for evaluating glycoconjugate vaccine immunogenicity.
Madore DV; Strong N; Eby R
Dev Biol Stand; 1999; 101():49-56. PubMed ID: 10566775
[TBL] [Abstract][Full Text] [Related]
16. Immunologic considerations for the development of conjugate vaccines.
Garner CV; Pier GB
Contrib Microbiol Immunol; 1989; 10():11-7. PubMed ID: 2510971
[No Abstract] [Full Text] [Related]
17. Pneumococcal vaccines.
Lancet; 1978 Jan; 1(8056):131-2. PubMed ID: 87558
[No Abstract] [Full Text] [Related]
18. Current status and prospects for some improved and new bacterial vaccines.
Robbins FC; Robbins JB
Annu Rev Public Health; 1986; 7():105-25. PubMed ID: 3521639
[No Abstract] [Full Text] [Related]
19. Review of meningococcal vaccines with emphasis on possible immunoprophylaxis of group B disease.
Frøholm LO
NIPH Ann; 1980 Dec; 3(2):67-74. PubMed ID: 6784045
[No Abstract] [Full Text] [Related]
20. [Conjugated pneumococcal vaccines].
Reinert P
Arch Pediatr; 1999; 6 Suppl 3():643s-646s. PubMed ID: 10429806
[No Abstract] [Full Text] [Related]
[Next] [New Search]
